Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
WASHINGTON — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream. The Food and Drug Administration posted its initial review of the drug Friday, … Read more
